financetom
Business
financetom
/
Business
/
What's Going On With Bank Of America (BAC) Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Bank Of America (BAC) Shares
Jan 14, 2025 8:37 AM

Bank of America Corp ( BAC ) shares are trading higher by 0.85% to $45.43 during Tuesday’s session. The stock is marginally higher following the release of softer-than-expected December Producer Price Index (PPI) data, as investors potentially viewed the report as a sign that inflationary pressures might be easing without requiring aggressive Federal Reserve intervention.

What To Know: As a major financial institution, Bank of America ( BAC ) is particularly sensitive to interest rate dynamics, given its reliance on net interest income—profits derived from the spread between interest earned on loans and interest paid on deposits.

Read Also: US Listed Chinese Stocks Rally on Strong Trade Data, Central Bank Support, Goldman Forecasts 20% Growth

The deceleration in monthly core PPI and the weaker annual figures suggest that inflation may be stabilizing, potentially reducing the need for the Federal Reserve to raise rates.

What Else: Lower-than-anticipated rate hikes could benefit Bank of America ( BAC ) by supporting loan demand and keeping borrowing costs manageable for its retail and commercial clients. Moreover, reduced inflation pressures could mitigate concerns about credit deterioration in the bank’s loan portfolio, as consumers and businesses face less financial strain.

Bank of America ( BAC ) also stands to gain from continued economic stability, as a less hawkish Fed reduces the risk of a hard landing that could curb credit growth and capital markets activity.

Read Also: US Electric Vehicle Sales Hit Record 1.3 Million Units In 2024, Despite Tesla Declines: Top 10 Bestselling Models List

How To Buy BAC Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Bank of America’s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, BAC has a 52-week high of $48.08 and a 52-week low of $31.27.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thoma Bravo to buy Verint in $2 billion deal
Thoma Bravo to buy Verint in $2 billion deal
Aug 25, 2025
Aug 25 (Reuters) - Private equity firm Thoma Bravo will acquire Verint ( VRNT ) in a $2 billion deal, including debt, the customer experience automation firm said on Monday. ...
SLB's OneSubsea JV Obtains Equinor Offshore Contract
SLB's OneSubsea JV Obtains Equinor Offshore Contract
Aug 25, 2025
08:50 AM EDT, 08/25/2025 (MT Newswires) -- SLB (SLB) said Monday that its OneSubsea joint venture was awarded an engineering, procurement, and construction contract by Equinor ( EQNR ) for a 12-well, electric subsea production system off the coast of Norway. Financial details weren't disclosed. OneSubsea is a joint venture between SLB, engineering and services firm Aker Solutions, and offshore...
Evolus Says Mid-Face Restoration Product Shows Statistical Superiority in Pivotal Study
Evolus Says Mid-Face Restoration Product Shows Statistical Superiority in Pivotal Study
Aug 25, 2025
08:44 AM EDT, 08/25/2025 (MT Newswires) -- Evolus ( EOLS ) said Monday that its pivotal study of Evolysse Sculpt showed statistical superiority to Restylane-Lyft in effectiveness for mid-face volume deficit. The injectable hyaluronic acid gel product, designed to restore mid-face volume, met its primary endpoint of non-inferiority, as well as the secondary endpoint of percent of cheeks demonstrating a...
Cenovus Energy Price Target Raised at ATB, Desjardins
Cenovus Energy Price Target Raised at ATB, Desjardins
Aug 25, 2025
08:46 AM EDT, 08/25/2025 (MT Newswires) -- Analysts at ATB Capital Markets and Desjardins raised their price targets on Cenovus Energy Inc. ( CVE ) to $28 from $25, and to $29 from $27.50, respectively. ATB analyst Patrick J. O'Rourke maintained an Outperformer rating on shares of the Calgary-based integrated oil and gas company following its August 22 announcement that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved